RxSight RXST
NASDAQ RXST
$5.32 -0.06 (-1.12%)
At close: Nov 13, 2026 · 4:00 PM EST

RxSight (RXST) Net Income Attributable to Noncontrolling Interests (2023 - 2024)

Updated

Analysis

RxSight (RXST) Net Income Attributable to Noncontrolling Interests (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 6.00 Mn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn -
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn -
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 1.60 Mn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 9.00 Mn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn -2.00 Mn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn -6.10 Mn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 123.00 Mn
10 RxSight 223.05 Mn -31.65 Mn 18.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 639,000.00
Sep 30, 2023 13,000.00
API Access

RxSight Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RXST&period=max&api_key=YOUR_API_KEY